Search for Faculty

Photo: Luke Wittenburg

Luke Wittenburg
Assistant Professor
Surgical & Radiological Sciences

218 CCAH
Davis, CA 95616

+1 530 754 5711
lwittenburg@ucdavis.edu

   

Research Focus

Developmental Cancer Therapeutics

Education

1999 BS Animal Science, New Mexico State University, Las Cruces, NM
2004 DVM Veterinary Medicine, Colorado State University, Fort Collins, CO
2010 PhD Cell and Molecular Biology, Colorado State University, Fort Collins, CO
2013 DACVCP Veterinary Clinical Pharmacology, Colorado State University, Fort Collins, CO

Active Research Grants

Co-Investigator, Pharmacokinetics and pharmacodynamics of intramuscular administration of alfaxalone in domestic chickens, Matt Johnson (Principal Investigator), Colorado State CVMBS Young Investigator Grant

Principal Investigator, Utilization of a limited-sampling pharmacokinetic model to correlate myelosuppression with doxorubicin exposure in dogs with osteocarcoma, (Principal Investigator), Colorado State University Flint Animal Cancer Center

Most Recent 10 Publications

  • Luke Wittenburg: The effects of mepivacaine hydrochloride on antimicrobial activity and mechanical nociceptive threshold during amikacin sulfate regional limb perfusion in the horse 2016 Colbath AC, Wittenburg LA, Gold JR, Mcllwraith, CW, Moorman VJ The effects of mepivacaine hydrochloride on antimicrobial activity and mechanical nociceptive threshold during amikacin sulfate regional limb perfusion in the horse Veterinary Surgery,
  • Luke Wittenburg: Limited sampling pharmacokinetics of subcutaneous ondansetron in healthy geriatric cats, cats with chronic kidney disease, and cats with liver disease 2015 Fitzpatrick RL, Wittenburg LA, Hansen RJ, Gustafson DL, Quimby JM Limited sampling pharmacokinetics of subcutaneous ondansetron in healthy geriatric cats, cats with chronic kidney disease, and cats with liver disease Journal of Veterinary Pharmacology and Therapeutics,
  • Luke Wittenburg: Pharmacokinetics and bioavailability of orbifloxacin oral suspension in New Zealand white rabbits (oryctolagus cuniculus) 2015 Watson MK, Wittenburg LA, Bui CT, Jarosz KA, Gustafson DL, Johnston MS Pharmacokinetics and bioavailability of orbifloxacin oral suspension in New Zealand white rabbits (oryctolagus cuniculus) American Journal of Veterinary Research,
  • Luke Wittenburg: Pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban after oral and intravenous administration to cats 2015 Myers JA, Wittenburg LA, Olver CS, Martinez CM, Bright JM Pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban after oral and intravenous administration to cats American Journal of Veterinary Research,
  • Luke Wittenburg: Endometrial tissue and blood plasma concentration of ceftiofur and metabolites following intramuscular administration of ceftiofur crystalline free acid to mares 2014 Scofield D, Black J, Wittenburg L, Gustafson D, Ferris R, Hatzel J, Traub-Dargatz J, McCue P Endometrial tissue and blood plasma concentration of ceftiofur and metabolites following intramuscular administration of ceftiofur crystalline free acid to mares Equine Veterinary Journal,
  • Luke Wittenburg: Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs 2014 Arnold TS, Wittenburg LA, Powell CC Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs Veterinary Ophthalmology,
  • Luke Wittenburg: Development of a limited-sampling model for prediction of doxorubicin exposure in dogs 2014 Wittenburg LA, Thamm DH, Gustafson DL Development of a limited-sampling model for prediction of doxorubicin exposure in dogs Veterinary and Comparative Oncology,
  • Luke Wittenburg: Phase I clinical trial and pharmacodynamics evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma 2014 Barnard RA, Wittenburg LA, Amaravadi RK, Gustafson D, Thorburn A, Thamm DH Phase I clinical trial and pharmacodynamics evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma Autophagy,
  • Luke Wittenburg: A pilot phase II study of efficacy and biosafety of doxorubicin chemotherapy in tumor-bearing equidae 2013 Theon AP, Pusterla N, Magdesian KG, Wittenburg L, Marmulak T, Wilson WD A pilot phase II study of efficacy and biosafety of doxorubicin chemotherapy in tumor-bearing equidae Journal of Veterinary Internal Medicine,
  • Luke Wittenburg: Equine endometrial tissue concentration of fluconazole following oral administration 2013 Scofield DB, Wittenburg LA, Ferris RA, Gustafson DL, McCue PM Equine endometrial tissue concentration of fluconazole following oral administration Journal of Equine Veterinary Sciences,